Joshua Brody, MD

GRACE Guest Faculty - Blood Cancers
Mount Sinai Hospital
New York
NY
Specialties
Cancer (Oncology) Hematology-Oncology

ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology Cancer (Oncology), Hematology-Oncology, The Mount Sinai Hospital

The Lymphoma Immunotherapy Program at the Mount Sinai School of Medicine and the Brody Lab focus on basic and applied tumor immunology (particularly in lymphoma, melanoma, and ovarian adenocarcinoma). Dr. Brody's other areas of interest include: bioinformatic-based collaborations tracking T-cell responses using high-throughput sequencing of the entire TCRbV repertoire and studies of small-molecule inhibitors of lymphocyte signal transduction, e.g. PI3K, mTOR, btk. The  lab has the rare opportunity to both perform correlative studies on primary patient tumor samples from early phase clinical trials and to continually develop advancements in those trials based on what is learned. The core mission is the translation of basic science in tumor immunology into novel clinical trials and development of correlative science associated with those trials to gain a greater understanding of mechanistic-clinical correlates.
 

 

Conflict of Interest

None

We are happy to bring you updates to the GRACE Blood Cancer Video Library.

For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Assistant Professor of Medicine, Hematology and Medical Oncology and Director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at Mount Sinai Hospital joins us to discuss updates from ASH 2019.

For this video, Dr. Brody shares information on Mantle Cell Lymphoma, and the exciting outcomes from CAR-T Cell therapy trials.

We are happy to bring you updates to the GRACE Blood Cancer Video Library.

For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Assistant Professor of Medicine, Hematology and Medical Oncology and Director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at Mount Sinai Hospital joins us to discuss updates from ASH 2019.

For this video, he shares information on Bi-specific Therapy and new treatments for diffuse large B-Cell lymphoma (DLBCL) and follicular lymphoma.

We are happy to bring you updates to the GRACE Blood Cancer Video Library.

For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Assistant Professor of Medicine, Hematology and Medical Oncology and Director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at Mount Sinai Hospital joins us to discuss updates from ASH 2019.

For this video, Dr. Brody shares information on CLL (Chronic Lymphocytic Leukemia) and a new generation of BTK Inhibitors

Community Forum

JOIN THE CONVERSATION

Hi Carole, Welcome to Grace. If the adrenal is the only place that cancer has been seen since your lobectomy it could be that it's what's known as a precocious metastasis/oligoprogression...

Carole,

These approaches haven't been directly compared, and it really depends on who can do the job and what they say is appropriate to expect in terms of side effects. In...

Hi CDaniele,
Welcome to Grace. If the TKI is working except for one or 2 places local treatment such as radiation can be used to get rid of the resistant cells...

I forgot to tell you that Grace is having its annual OncTalk live forum online Saturday, Dec. 11 at 8 am Pacific and 11 am Eastern
It will be invaluable to...

This is indeed a happy Thanksgiving in our house. I'll post about it at soon but we've just come out of a dark place and are feeling so hopeful today.
As...

Janine I am so happy to hear things like this. What you can or feel comfortable sharing, know that we are here! You are a very important part of the GRACE...

Hi and welcome to Grace.  I'm sorry your sister-in-law is going through this it's so unsettling, to say the least.  Cancer travels through the lymph system but also through blood vessels. ...